References
- Szegedi I, Szapáry L, Csécsei P, et al. Potential biological markers of atrial fibrillation: a chance to prevent cryptogenic stroke. Biomed Res Int. 2017;2017(8153024):1–10.
- Adams HP Jr., Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41.
- Love S. Oxidative stress in brain ischemia. Brain Pathol. 1999;9(1):119–131.
- Rybak-Wolf A, Stottmeister C, Glažar P, et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell. 2015;58(5):870–885.
- Chen L, Huang C, Wang X, et al. Circular RNAs in eukaryotic cells. Curr Genomics. 2015;16(5):312–318.
- Bolha L, Ravnik-Glavač M, Glavač D. Circular RNAs: biogenesis, function, and a role as possible cancer biomarkers. Int J Genomics. 2017;2017(6218353):1–19.
- Chen W, Wang H, Feng J, et al. Overexpression of circRNA circUCK2 attenuates cell apoptosis in cerebral ischemia-reperfusion injury via miR-125b-5p/GDF11 signaling. Mol Ther Nucleic Acids. 2020;22(673–683):673–683.
- Huang K, Yang C, Zheng J, et al. Effect of circular RNA, mmu_circ_0000296, on neuronal apoptosis in chronic cerebral ischaemia via the miR-194-5p/Runx3/Sirt1 axis. Cell Death Discov. 2021;7(1):124.
- Vishnoi A, Rani S. MiRNA biogenesis and regulation of diseases: an overview. Methods Mol Biol. 2017;1509(1–10). DOI:10.1007/978-1-4939-6524-3_1
- Li L, Dong L, Zhao J, et al. Circulating miRNA-3552 as a potential biomarker for ischemic stroke in rats. Biomed Res Int. 2020;2020(4501393). DOI:10.1155/2020/4501393
- Zhang H, Chen G, Qiu W, et al. Plasma endothelial microvesicles and their carrying miRNA-155 serve as biomarkers for ischemic stroke. J Neurosci Res. 2020;98(11):2290–2301.
- Qian J, Li R, Wang YY, et al. MiR-1224-5p acts as a tumor suppressor by targeting CREB1 in malignant gliomas. Mol Cell Biochem. 2015;403(1–2):33–41.
- Sibley CR, Seow Y, Curtis H, et al. Silencing of Parkinson’s disease-associated genes with artificial mirtron mimics of miR-1224. Nucleic Acids Res. 2012;40(19):9863–9875.
- Feng Y, Li Y, Zhang Y, et al. miR-1224 contributes to ischemic stroke-mediated natural killer cell dysfunction by targeting Sp1 signaling. J Neuroinflammation. 2021;18(1):133.
- Zhou D, Huang Z, Zhu X, et al. Circular RNA 0025984 ameliorates ischemic stroke injury and protects astrocytes through miR-143-3p/TET1/ORP150 pathway. Mol Neurobiol. 2021;58(11):5937–5953.
- Ren Y, Gao XP, Liang H, et al. LncRNA KCNQ1OT1 contributes to oxygen-glucose-deprivation/reoxygenation-induced injury via sponging miR-9 in cultured neurons to regulate MMP8. Exp Mol Pathol. 2020;112(104356):104356.
- Westholm JO, Miura P, Olson S, et al. Genome-wide analysis of drosophila circular RNAs reveals their structural and sequence properties and age-dependent neural accumulation. Cell Rep. 2014;9(5):1966–1980.
- Floris G, Zhang L, Follesa P, et al. Regulatory role of circular rnas and neurological disorders. Mol Neurobiol. 2017;54(7):5156–5165.
- Wu F, Han B, Wu S, et al. Circular RNA TLK1 aggravates neuronal injury and neurological deficits after ischemic stroke via miR-335-3p/TIPARP. J Neurosci. 2019;39(37):7369–7393.
- Shi ZZ, Wang WJ, Chen YX, et al. The miR-1224-5p/TNS4/EGFR axis inhibits tumour progression in oesophageal squamous cell carcinoma. Cell Death Dis. 2020;11(7):597.
- Chen T, Yan D, Cheng X, et al. miR-1224-5p enhances hepatic lipogenesis by targeting adenosine monophosphate-activated protein kinase α1 in male mice. Endocrinology. 2018;159(5):2008–2021.
- Cheng W, Liu GP, Kong D, et al. Downregulation of miR-1224 protects against oxidative stress-induced acute liver injury by regulating hepatocyte growth factor. J Cell Biochem. 2019;120(8):12369–12375.
- Ozek C, Krolewski RC, Buchanan SM, et al. Growth differentiation factor 11 treatment leads to neuronal and vascular improvements in the hippocampus of aged mice. Sci Rep. 2018;8(1):17293.
- Loffredo FS, Steinhauser ML, Jay SM, et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013;153(4):828–839.
- Zhang W, Guo Y, Li B, et al. GDF11 rejuvenates cerebrovascular structure and function in an animal model of alzheimer’s disease. J Alzheimers Dis. 2018;62(2):807–819.
- Anqi X, Ruiqi C, Yanming R, et al. Neuroprotective potential of GDF11 in experimental intracerebral hemorrhage in elderly rats. J Clin Neurosci. 2019;63(182–188. DOI:10.1016/j.jocn.2019.02.016
- Hudobenko J, Ganesh BP, Jiang J, et al. Growth differentiation factor-11 supplementation improves survival and promotes recovery after ischemic stroke in aged mice. Aging (Albany NY). 2020;12(9):8049–8066.